title: Clinically significant ticagrelor induced conduction abnormalities following percutaneous coronary intervention.
authors.affiliation: Department of Interventional Cardiology, Excela Health Westmoreland Hospital, United States. Electronic address: Nbaker@excelahealth.org.
authors.forename: Nevin C
authors.initials: NC
authors.lastname: Baker
authors.affiliation: Department of Interventional Cardiology, Excela Health Westmoreland Hospital, United States.
authors.forename: Wadih
authors.initials: W
authors.lastname: Nadour
authors.affiliation: Department of Electrophysiology, Excela Health Westmoreland Hospital, United States.
authors.forename: Mati
authors.initials: M
authors.lastname: Friehling
mesh_terms: D054058:Acute Coronary Syndrome / Q000000981:diagnostic imaging / Q000628:therapy*; D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D054537:Atrioventricular Block / Q000139:chemically induced / Q000188:drug therapy*; D017023:Coronary Angiography; D054855:Drug-Eluting Stents; D006801:Humans; D008297:Male; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D000068799:Prasugrel Hydrochloride / Q000627:therapeutic use; D000077486:Ticagrelor; D016896:Treatment Outcome
chemical_list: D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine
keywords: Acute coronary syndrome; Atrioventricular block; Bradycardia; Ticagrelor